Synthesis, in vitro and in silico enzymatic inhibition assays, and toxicity evaluations of new 4,5-diphenylimidazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis, in vitro and in silico enzymatic inhibition assays, and toxicity evaluations of new 4,5-diphenylimidazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors
Authors
Keywords
-
Journal
MEDICINAL CHEMISTRY RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-16
DOI
10.1007/s00044-021-02734-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies
- (2020) Mohammad Sadegh Asgari et al. MOLECULAR DIVERSITY
- New acridine-9-carboxamide linked to 1,2,3-triazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors: design, synthesis, in vitro, and in silico biological evaluations
- (2020) Nima Sepehri et al. MEDICINAL CHEMISTRY RESEARCH
- Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion
- (2019) Gao-Jie Ye et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies
- (2019) Mohammad Sadegh Asgari et al. BIOORGANIC CHEMISTRY
- Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors
- (2019) Mina Saeedi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors
- (2019) Nafise Asemanipoor et al. BIOORGANIC CHEMISTRY
- Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes
- (2018) Maryam Mohammadi-Khanaposhtani et al. BIOORGANIC CHEMISTRY
- New 6-amino-pyrido[2,3- d ]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α -glucosidase inhibition, molecular modeling and kinetic study
- (2018) Mehdi Adib et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification and anti-cancer activity in 2D and 3D cell culture evaluation of an Iranian isolated marine microalgae Picochlorum sp. RCC486
- (2018) Mohammad Haji Abolhasani et al. DARU-Journal of Pharmaceutical Sciences
- Organocatalyzed solvent free an efficient novel synthesis of 2,4,5-trisubstituted imidazoles for α-glucosidase inhibition to treat diabetes
- (2015) Muhammad Yar et al. BIOORGANIC CHEMISTRY
- Synthesis,In vitroand Docking Studies of New Flavone Ethers asα-Glucosidase Inhibitors
- (2015) Syahrul Imran et al. Chemical Biology & Drug Design
- Synthesis of novel flavone hydrazones: In-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies
- (2015) Syahrul Imran et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Imidazoles as Potential Antifungal Agents: A Review
- (2015) Nidhi Rani et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice
- (2012) Giuseppe Derosa et al. Archives of Medical Science
- Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
- (2008) Antonio Cervera et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The SWISS-MODEL Repository and associated resources
- (2008) F. Kiefer et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More